Carolina Trkulja

Title: Carolina Trkulja: Innovator in Antibody Development

Introduction

Carolina Trkulja is a prominent inventor based in Borås, Sweden. She has made significant contributions to the field of antibody development, focusing on innovative methods for epitope selection. With a total of 4 patents to her name, her work is paving the way for advancements in therapeutic antibodies.

Latest Patents

Trkulja's latest patents include groundbreaking methods for epitope selection. One of her inventions, titled "Methods for Epitope Selection," relates to new techniques for identifying antigenic epitopes in proteins. This method involves exposing proteins to limited proteolysis, allowing for the generation of functional antibodies against specific epitopes. Another notable patent, "Multi-Protease Method," describes a process for identifying epitopes on proteins that can be bound by antibodies through a combination of proteolysis steps. These inventions are crucial for the development of targeted therapies.

Career Highlights

Carolina Trkulja is currently associated with Oblique Therapeutics AB, where she continues to innovate in the field of antibody research. Her work is characterized by a commitment to enhancing the efficacy of therapeutic antibodies through her patented methods.

Collaborations

Trkulja collaborates with esteemed colleagues, including Owe Orwar and Max Davidson, who contribute to her research endeavors. Their combined expertise fosters a dynamic environment for innovation in antibody development.

Conclusion

Carolina Trkulja's contributions to the field of antibody development through her innovative patents are noteworthy. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.